1. Home
  2. ZENV vs NEPH Comparison

ZENV vs NEPH Comparison

Compare ZENV & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zenvia Inc.

ZENV

Zenvia Inc.

N/A

Current Price

$1.25

Market Cap

70.8M

Sector

Technology

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.02

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZENV
NEPH
Founded
2005
1997
Country
Brazil
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.8M
60.0M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
ZENV
NEPH
Price
$1.25
$5.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
28.3K
74.6K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$201,426,369.00
$17,930,000.00
Revenue This Year
$12.75
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$36.15
Revenue Growth
24.80
32.36
52 Week Low
$1.02
$1.39
52 Week High
$3.03
$6.42

Technical Indicators

Market Signals
Indicator
ZENV
NEPH
Relative Strength Index (RSI) 49.91 48.33
Support Level $1.13 $4.83
Resistance Level $1.27 $5.97
Average True Range (ATR) 0.07 0.63
MACD 0.01 -0.03
Stochastic Oscillator 76.52 28.93

Price Performance

Historical Comparison
ZENV
NEPH

About ZENV Zenvia Inc.

Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: